首页> 外文期刊>Human Molecular Genetics >Cochlin immunostaining of inner ear pathologic deposits and proteomic analysis in DFNA9 deafness and vestibular dysfunction.
【24h】

Cochlin immunostaining of inner ear pathologic deposits and proteomic analysis in DFNA9 deafness and vestibular dysfunction.

机译:内耳病理沉积物的Cochlin免疫染色和DFNA9耳聋和前庭功能障碍的蛋白质组学分析。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Seven missense mutations and one in-frame deletion mutation have been reported in the coagulation factor C homology (COCH) gene, causing the adult-onset, progressive sensorineural hearing loss and vestibular disorder at the DFNA9 locus. Prevalence of COCH mutations worldwide is unknown, as there is no systematic screening effort for late-onset hearing disorders; however, to date, COCH mutations have been found on four continents and the possibility of COCH playing an important role in presbycusis and disorders of imbalance has been considered. Cochlin (encoded by COCH) has also been shown as a major target antigen for autoimmune sensorineural hearing loss. In this report, we present histopathology, immunohistochemistry and proteomic analyses of inner ear tissues from post-mortem DFNA9 temporal bone samples of an individual from a large Dutch kindred segregating the P51S mutation and adult human unaffected controls, and wild-type (+/+) and Coch null (-/-) knock-out mice. DFNA9 is an inner ear disorder with a unique histopathology showing loss of cellularity and aggregation of abundant homogeneous acellular eosinophilic deposits in the cochlear and vestibular labyrinths, similar to protein aggregation in well-known neurodegenerative disorders. By immunohistochemistry on the DFNA9 temporal bone sections, we have shown cochlin staining of the characteristic cochlear and vestibular deposits, indicating aggregation of cochlin in the same structures in which it is normally expressed. Proteomic analysis identified cochlin as the most abundant protein in mouse and human cochleae. The high-level expression and stability of cochlin in the inner ear, even in the absence and severe atrophy of the fibrocytes that normally express COCH, are shown through these studies and further elucidate the pathobiologic events occurring in DFNA9 leading to hearing loss and vestibular dysfunction.
机译:凝血因子C同源性(COCH)基因中已报告7个错义突变和1个框内缺失突变,导致DFNA9基因座的成年发作,进行性感觉神经性听力减退和前庭障碍。目前尚不知道全球COCH突变的患病率,因为没有针对迟发性听力障碍的系统筛查工作。然而,迄今为止,已经在四大洲发现了COCH突变,并且已经考虑了COCH在老花眼和失衡症中起重要作用的可能性。 Cochlin(由COCH编码)也已被证明是自身免疫性感音神经性听力损失的主要靶抗原。在本报告中,我们介绍了来自大型荷兰血统个体的验尸DFNA9颞骨样本的内耳组织的组织病理学,免疫组化和蛋白质组学分析,该样本分离了P51S突变和成年人类未受影响的对照以及野生型(+ / + )和Coch无效(-/-)敲除小鼠。 DFNA9是一种内耳疾病,具有独特的组织病理学表现,显示出耳蜗和前庭迷宫的细胞消失和大量均匀的无细胞嗜酸性粒细胞沉积的聚集,类似于众所周知的神经退行性疾病中的蛋白质聚集。通过对DFNA9颞骨切片进行免疫组织化学,我们已显示特征性耳蜗和前庭沉积物的Cochlin染色,表明Cochlin在正常表达的相同结构中聚集。蛋白质组学分析确定了Cochlin是小鼠和人耳蜗中最丰富的蛋白质。通过这些研究显示,即使没有正常表达COCH的纤维细胞缺失或严重萎缩,内耳中的Cochlin仍能高水平表达和稳定,从而进一步阐明DFNA9中导致听力损失和前庭功能障碍的病理生物学事件。 。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号